-
Innovation Ranking
NewInnovation Ranking – Krka dd Novo Mesto
Krka dd Novo Mesto (Krka) is a manufacturer and distributor of pharmaceutical products. It provides prescription pharmaceuticals, non-prescription products, and animal health products. The company’s prescription products are for cardiovascular diseases, diseases of alimentary tract and metabolism, central nervous system, oncology, infections, and other indications. Krka also provides non-prescription products such as cold and cough products, analgesics, vitamin and mineral products, nasal products, and hair care products, among others. The company’s animal health products include antimicrobials, disinfectants, and others. It...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DD-01 in Obesity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DD-01 in Obesity report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DD-01 in Obesity Drug Details: DD-01 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DD-04107 in Pruritus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DD-04107 in Pruritus report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.DD-04107 in Pruritus Drug Details: Parentide (DD-04107) is under development for the treatment of pruritus...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tofacitinib in Ulcerative Colitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tofacitinib in Ulcerative Colitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tofacitinib in Ulcerative Colitis Drug Details: Tofacitinib (PGN-600) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DD-04107 in Chronic Urticaria Or Hives
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DD-04107 in Chronic Urticaria Or Hives report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.DD-04107 in Chronic Urticaria Or Hives Drug Details: Parentide (DD-04107) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DD-01 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DD-01 in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DD-01 in Type 2 Diabetes Drug Details: DD-01 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – LT-1001 in Chemotherapy Induced Peripheral Neuropathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LT-1001 in Chemotherapy Induced Peripheral Neuropathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LT-1001 in Chemotherapy Induced Peripheral Neuropathy Drug Details: LT-1001 (PC-SOD,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PLX-038 in Ependymoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PLX-038 in Ependymoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PLX-038 in Ependymoma Drug Details: PLX-038 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PLX-038 in Recurrent Medulloblastoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PLX-038 in Recurrent Medulloblastoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PLX-038 in Recurrent Medulloblastoma Drug Details: PLX-038 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – LT-1001 in Acute Respiratory Distress Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LT-1001 in Acute Respiratory Distress Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LT-1001 in Acute Respiratory Distress Syndrome Drug Details: LT-1001 (PC-SOD,...